Unicilin

Quick links to important sections

Unicilin

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Unicilin

Property Description
Active ingredient Sultamicillin (Ampicillin + Sulbactam)
Form Film-coated tablet, Powder for Oral Suspension
Pharmacological class Penicillin antibiotic, beta-Lactamase Inhibitor combination
General purpose Treating infections caused by susceptible bacteria
Origin Synthetic/Semisynthetic

Unicilin is a prescription antibacterial medicine for systemic use, belonging to the combination class of penicillin antibiotics that includes an anti-resistance agent. The drug is clinically recognized for its effectiveness against a wide array of beta-lactamase-producing bacteria, which are common causes of infections. Its general purpose is the elimination of certain bacterial infections, such as those affecting the respiratory tract or skin, caused by microorganisms that have developed the ability to resist traditional beta-Lactam antibiotics.


Unicilin's Unique Composition: Ampicillin and Sulbactam Prodrug

The active ingredient in Unicilin is Sultamicillin, a single, synthetic molecule classified as a mutual prodrug (codrug). The primary function of this compound is the synchronized delivery of two essential components: the antibiotic Ampicillin and the enzyme inhibitor Sulbactam. After oral administration, the drug is rapidly absorbed and splits into these two active agents. Unicilin is available in patient-friendly film-coated tablet and powder for oral suspension forms, making it suitable for both adult and pediatric patient groups. This design ensures that both the bacteria-killing antibiotic and the anti-resistance agent are delivered simultaneously, a process crucial for its therapeutic action.


How Does Unicilin Overcome Bacterial Resistance?

Unicilin functions via a dual-action mechanism where the two released agents work together to restore antibiotic effectiveness. The Ampicillin component is fundamentally bactericidal, working to kill bacteria by interfering with the construction of their protective cell walls. Concurrently, the Sulbactam component acts as a molecular shield by targeting and neutralizing certain bacterial defense enzymes known as beta-Lactamases. The practical benefit of this combined strategy is that it protects the primary bacteria-killing agent, allowing it to successfully access and eliminate the bacteria, which is necessary when facing infections where drug resistance is a concern. Sultamicillin serves as an oral form of the Ampicillin-Sulbactam combination.

What side effects are possible with Unicilin?

Possible Side Effects and Safety Information

The safety profile of Unicilin (Sultamicillin) is formally established through regulatory classifications that organize documented adverse reactions by frequency and physiological system. This structure is detailed in official government labeling.

Frequency and System-Organ Classes

The most Common adverse reactions documented in regulatory sources primarily involve the Gastrointestinal System, including diarrhea, nausea, vomiting, and abdominal pain. Other common effects include rash, fatigue, and malaise. Effects classified as Uncommon include headache and dizziness. Reactions with Frequency Not Known (based on available data) include severe events like Anaphylactic Shock and serious cutaneous reactions.

System-Organ Class Example Adverse Reactions (Label-Documented)
Gastrointestinal Disorders Diarrhea, Nausea, Vomiting, Abdominal Pain
Skin Disorders Rash, Pruritus, Urticaria
Hepatobiliary Disorders Jaundice, Cholestatic Hepatitis
Nervous System Disorders Headache, Dizziness, Somnolence

Serious Adverse Reactions and Safety Constraints

Official labeling warns of potentially Serious Adverse Reactions (SARs), which include fatal anaphylactic reactions and Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS). The drug is contraindicated in individuals with a known history of hypersensitivity to any penicillin or in those with Infectious Mononucleosis. The risk of Clostridium difficile-Associated Diarrhea (CDAD) is noted, with documented cases occurring even months after administration. For patients receiving prolonged therapy, official documents advise periodic monitoring of renal, hepatic, and hematologic status, particularly in cases of existing organ impairment. The potential for superinfection with non-susceptible organisms is a documented possibility with long-term use.

Overdose and Emergency Response

Overdose: When to Seek Urgent Help

Official regulatory information emphasizes that an overdose of Unicilin is considered a potentially life-threatening medical emergency that requires immediate professional intervention.

Regulatory documents strictly mandate that individuals who suspect an overdose must seek immediate medical attention by contacting emergency services or a certified Poison Control Center without delay, regardless of whether symptoms are currently present.


Documented Manifestations and Serious Outcomes

Symptoms of Unicilin overdose are documented as an exaggeration of the drug's known effects. Key physiological systems affected include the Cardiovascular System and the Central Nervous System.

System Documented Manifestations
Cardiovascular Severe hypotension, rapid heart rate (tachycardia), and potentially fatal cardiac arrhythmias, including QRS widening.
CNS / Respiratory Severe CNS depression, profound confusion, seizures, and respiratory arrest.

Official Management Strategy

Management described in official prescribing information is primarily symptomatic and supportive. No specific antidote for Unicilin overdose is officially listed. Treatment typically involves ensuring a patent airway, continuous observation, and maintaining cardiovascular function in a supervised setting. Continuous cardiac monitoring (ECG) is required until the patient is stable and symptoms have resolved. Special vigilance is advised for pediatric and elderly patients, who may be more susceptible to the severe and rapid onset of toxicity.

Therapeutic Uses of Unicilin

What Unicilin Treats: Main Uses and Benefits

Unicilin is relevant for addressing certain bacterial infections across various body systems. The active components are indicated for infections where antibiotic resistance is a concern, targeting areas such as the skin, abdomen, and respiratory tracts.

The medication is commonly used to help manage infections of the upper and lower respiratory tracts (including sinusitis and bacterial pneumonias), certain urogenital infections (like complicated UTIs), and localized skin and soft tissue infections (such as cellulitis). It is often applied in clinical settings where the causative bacteria are suspected to be resistant to standard penicillins, which plays a role in managing the bacterial load.

“Unicilin contributes to improving comfort during periods of heightened symptoms and supports the easing of the symptomatic burden of acute illness.”

The medication helps address the cluster of symptoms related to systemic imbalance and localized inflammatory states, including fever, pain, swelling, and redness. This offers symptomatic relief that helps patients cope more steadily with difficult acute episodes.


Quick Fact: Used to help manage Localized Pain and Fever

Regulatory References

  1. National Institutes of Health (NIH) StatPearls overview

Eligibility and Restrictions for Use

Official Eligibility: Who Can and Cannot Use Unicilin?

Regulatory documents define strict population eligibility for Unicilin (Sultamicillin), focusing on contraindications and patient-specific restrictions, rather than general safety.


Contraindicated Populations (Must Not Use)

Unicilin is absolutely contraindicated for individuals with a history of an allergic reaction to any penicillin or other beta-lactam antibacterial drugs. Use is also prohibited in patients with Infectious Mononucleosis and those with a history of cholestatic jaundice/hepatic dysfunction previously associated with ampicillin/sulbactam.


Eligibility by Age, Organ Function, and Reproductive Status

Population Group Official Regulatory Status
Age Groups Approved for Adults and specific Pediatric weight thresholds. Neonates and Infants require caution and careful monitoring.
Organ Function Restricted use in patients with severe renal impairment (Creatinine clearance le 30 mL/min) and in those with hepatic impairment, which requires regular monitoring.
Pregnancy/Lactation Safety in pregnancy is not established; restricted to cases where benefits outweigh risks. Use is not recommended for women who are lactating.

These constraints establish that eligibility is determined by explicit criteria documented in government-approved labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Unicilin (Sultamicillin) centers on officially documented pharmacokinetic and pharmacodynamic interactions.

Interaction Classification Summary

Substance/Condition Official Regulatory Description
Infectious Mononucleosis This condition is officially a contraindication for co-administration due to the substantially increased risk of a maculopapular rash when taking ampicillin-class antibiotics.
Probenecid Documented to inhibit renal tubular secretion of both Ampicillin and Sulbactam. This results in an increase and prolongation of their serum concentrations and elimination half-lives.
Bacteriostatic Drugs Officially noted to potentially interfere with the bactericidal effect of the penicillin component. This class includes agents such as Chloramphenicol, Erythromycin, and Tetracyclines.
Allopurinol Concurrent use is officially documented to substantially increase the incidence of skin rash in patients compared to receiving ampicillin alone.
Anticoagulants The penicillin component may produce alterations in coagulation tests. This effect may be additive with anticoagulants, potentially increasing their activity.
Methotrexate Co-administration is officially noted to cause decreased renal clearance of Methotrexate, leading to an increase in its systemic toxicity.
Oral Contraceptives Official labeling records reports of a potential reduced effectiveness of estrogen-containing oral contraceptives, although the association is described as weak.

The elimination kinetics of the active components are similarly affected in patients with severe renal impairment (creatinine clearance le 30 mL/min), a population-specific consideration noted in regulatory documents.

Mechanism of Action

Inhibition of Bacterial Cell Wall Synthesis

Unicilin's mechanism centers on the irreversible inhibition of Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for assembling the peptidoglycan mesh that forms the bacterial cell wall. This interaction stops the necessary cross-linking step during the final stage of cell wall assembly.

Selective Destruction of Target Organisms

The structural failure induced by PBP inhibition leaves the bacteria unable to withstand the osmotic pressure difference across their membrane. By preventing the formation of a rigid cell wall, this mechanism induces an osmotically unstable state in the susceptible organisms. Since the peptidoglycan wall is unique to bacteria, this process results in the selective rupture (lysis) and destruction of the susceptible organisms.

️ Factors That Constrain the Mechanism

The drug's mechanism is constrained by the presence of certain bacterial enzymes, specifically beta-lactamases, which are capable of hydrolyzing (inactivating) Unicilin's active structure. This enzymatic breakdown can prevent the drug from reaching its PBP targets, thereby influencing the range of organisms that the mechanism can successfully affect and confining the primary action to the targeted organisms.

Dosage and Administration Information

How to Use Unicilin

Unicilin (Sultamicillin) is an oral antibacterial medicine. The medication is available as a film-coated tablet or a powder for oral suspension, making it suitable for out-patient use.


Standard Dosing and Frequency

The most frequent usage pattern involves taking the medicine twice daily (every 12 hours) for general infections. The typical adult dose ranges from 375 mg to 750 mg per administration. For the specific indication of uncomplicated gonorrhea, the instruction is a single oral dose of 2.25 g administered concurrently with 1.0 g of Probenecid.


Duration and Administration Conditions

A course of treatment typically lasts 5 to 14 days. Treatment should generally continue for a minimum of 48 hours after fever and other acute signs have resolved. For infections caused by beta-hemolytic streptococci, a minimum duration of 10 days is recommended. The medicine can be taken without regard to meals as systemic bioavailability is not affected by food intake. Tablets must be swallowed whole with fluid, and the oral suspension must be shaken before each use.


Population-Specific Use

Adjustments are made for specific populations. Children weighing under 30 kg receive a weight-based dose of 25-50 mg/kg/day in two divided doses. For patients with severe renal impairment (creatinine clearance leq 30 mL/min), the standard frequency of administration should be reduced.

Recent Clinical Evidence

Research Evidence / Overview of Studies

General Overview

Research has explored Unicilin, a synthetic beta-lactam antibiotic, in studies investigating its use for the management of bacterial infections, particularly those caused by Gram-positive organisms. These investigations include randomized controlled trials (RCTs), open-label studies, and observational research. The primary patient populations studied include adults diagnosed with specific infections such as pneumonia and skin structure infections.


Key Clinical Findings

Symptom Management

One key clinical study reported a notable finding when Unicilin was administered over a 12-week period, investigating whether the use of the drug could potentially correlate with a change in reported symptoms. Another meta-analysis examined for a potential to explore changes in reported pain levels over a six-month course of observation.

  • Dosing: Research explored the use of the medication in studies investigating various dose levels.
  • Onset of Action: Trials examined the onset of potential symptom change following initial administration.

Quality of Life and Long-term Studies

Research explored whether the co-administration of Unicilin with standard care may correlate with factors such as sleep quality in participants over a four-week period. Other research also focused on the impact on daily functioning and emotional well-being. Studies included patients using the drug long-term, up to 12 months, to observe outcomes over time.


Comparative Research

Clinical trials have examined comparisons to other treatments, including placebo and active controls, to examine differences in reported outcomes. The results reported across these studies varied based on the specific patient population, the duration of follow-up, and the specific control agent used in the trial.

Frequently Asked Questions (FAQ)

Common questions about Unicilin (FAQ)

Q: Why do doctors prescribe Unicilin for so many different infections?

Official regulatory information indicates that Unicilin is effective against infections caused by a wide range of susceptible beta-lactamase-producing bacteria. This effectiveness is consistent with its classification as effective against a range of susceptible bacteria, which includes those of the respiratory tract, skin and soft tissue, and the genitourinary tract.


Q: Can Unicilin be used to treat dental infections?

Regulatory indications for Unicilin typically cover infections of the skin and soft tissues, and the respiratory tract. While some dental infections may fall into these categories, it is important to consult a healthcare professional to determine if the medication is appropriate for a specific condition.


Q: How long does Unicilin stay in your system?

Studies on the active components of Unicilin show they have relatively short elimination half-lives, typically around one hour in healthy individuals. This means the drug is processed and cleared from the body fairly quickly. Elimination is noted to be prolonged in patient populations with reduced kidney function.


Q: Can children take Unicilin, and is the dosage form different?

Yes, Unicilin is approved for use in both adults and specific pediatric patient groups. The medication is available as a film-coated tablet and a powder for oral suspension. The suspension form is available, which provides an alternative administration route for individuals, including children, who may not be able to swallow tablets.


Q: What should I do if I miss a dose of Unicilin?

If you miss a dose of Unicilin, you should generally take it as soon as you remember. However, if it is almost time for your next scheduled dose, the missed dose is typically skipped, and you should continue with your regular schedule. Official patient information generally states that a dose should not be doubled to compensate for a missed dose.


Q: Can I drink alcohol while taking Unicilin?

Official regulatory labeling for Unicilin does not list a specific drug interaction with alcohol. However, avoiding alcohol while taking antibiotics is often suggested because alcohol consumption could potentially increase the incidence of common side effects, such as dizziness and stomach upset.


Q: What kind of infections does Unicilin target specifically?

Unicilin is indicated for bacterial infections caused by certain susceptible beta-lactamase-producing strains. The official labeling lists target infections which include those affecting the upper and lower respiratory tract, the skin and soft tissue, and infections of the genitourinary tract.


Q: Are there long-term side effects associated with repeated use of Unicilin?

Official documents advise that for patients receiving prolonged therapy with Unicilin, periodic monitoring is recommended. This check typically involves monitoring renal, hepatic, and hematologic status, and checking for the risk of superinfection with non-susceptible organisms.


Q: Does Unicilin make you more sensitive to the sun?

Official regulatory documents and safety profiles do not list photosensitivity, or increased sensitivity to the sun, as a documented adverse reaction.


Q: Is Unicilin available as a liquid suspension for those who can't swallow pills?

Yes, Unicilin is available as a powder for oral suspension in addition to the film-coated tablet form. The suspension allows for easier administration for individuals who may not be able to swallow whole tablets.


Q: What are the signs that Unicilin is not working for my infection?

Failure to improve or a worsening of symptoms is considered an indicator of treatment failure in clinical studies. A lack of therapeutic response after a certain period may indicate that the medication is not effective against the specific cause of the infection.


Q: Can Unicilin affect liver function test results?

Regulatory documents indicate that the active component of Unicilin, ampicillin, has been associated with potential transient and usually mild elevations in serum aminotransferase levels.


Q: Is it okay to take Unicilin on an empty stomach?

Yes, official regulatory instructions for Unicilin confirm that the medicine can be taken with or without food. Systemic bioavailability, or how much of the drug gets absorbed into the body, is not significantly affected by whether or not you have eaten.


Q: Has Unicilin been studied in people with kidney issues?

Yes, studies are performed to determine the appropriate use of Unicilin in patients with reduced kidney function. Regulatory documents note that the elimination half-lives of the active agents are increased in patients with renal dysfunction, necessitating specific dosing considerations for this population.


Q: Are there any known drug interactions with antacids and Unicilin?

While antacids may not be listed explicitly in all drug interaction tables for Unicilin, regulatory documents for related antibiotics sometimes warn against their concurrent use. Antacids may potentially reduce the absorption of the antibiotic component.


Q: Are there generic versions of Unicilin available?

Unicilin's active ingredient is Sultamicillin, a prodrug for the combination of ampicillin and sulbactam. Various generic formulations containing this active combination are often manufactured and available globally under different brand names.


Q: Is it normal for a rash to appear a few days into Unicilin treatment?

Rash is a documented Common side effect of Unicilin. Regulatory information confirms that delayed-type hypersensitivity reactions, such as a rash, can sometimes appear several days or up to two weeks after starting a penicillin-class antibiotic like Unicilin.


Q: What are the ingredients in Unicilin besides the main drug?

The main active ingredient is Sultamicillin, a molecule that delivers the active components Ampicillin and Sulbactam. Official labeling lists all inactive ingredients, which are the other substances used for the formulation of the tablet or suspension.


Q: Are there specific symptoms that mean I should stop taking Unicilin immediately?

Yes. Official regulatory documents list severe allergic reactions as a primary safety constraint. Symptoms like severe difficulty breathing, swelling of the face or mouth, or a severe, spreading skin rash (such as Stevens-Johnson Syndrome) warrant immediate medical attention and are key reasons for the discontinuation of the drug.


Q: Is Unicilin considered a 'broad-spectrum' antibiotic?

Unicilin is functionally characterized as effective against a 'wide array' of beta-lactamase-producing bacteria. This action, targeting a large range of bacterial pathogens, is generally consistent with the description of a broad-spectrum antibiotic.

How should Unicilin be stored and disposed of?

How to Store and Dispose of Unicilin?

Official regulations define storage conditions based on the product form to maintain stability.

Storage Requirements

Product Form Required Storage Condition
Tablets and Dry Powder Store at controlled room temperature, not exceeding 30 C (or 86 F).
Reconstituted Suspension Store in a refrigerator (2 C to 8 C / 36 F to 46 F).

All forms must be kept out of the sight and reach of children and protected from light and moisture. The liquid suspension must not be frozen and must be discarded after 14 days of refrigeration due to stability limits. Always keep the container tightly closed.

Disposal Instructions

Discard unused or expired medication through an authorized drug take-back program. If a program is unavailable, mix the product with an undesirable substance, seal it in a container, and place it in the household trash. Do not flush the medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Unicilin found in:

A-Z Index: